Effect of the LumbaCure® Intervention on Elderly Patients Suffering From cLBP.
NCT ID: NCT06203886
Last Updated: 2024-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-12-11
2024-07-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation to Assess the Clinical Performance of the LumbaCure® Intervention on Chronic Low Back Pain Patients.
NCT06138002
Clinical Investigation to Assess the Clinical Effect of the LumbaCure® Intervention on Patients Suffering From Chronic Low Back Pain
NCT06662032
The Efficacy of the Kyrobak for Chronic Low Back Pain (LBP-2)
NCT02155283
Lumbar Assistive Exoskeletons in Caregiving
NCT05473208
Geriatrics Balance and Low Back Pain Study
NCT02031562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Intervention arm
LumbaCure robotic device
LumbaCure
LumbaCure® is a device developed to induce specific mobilization of the lower back in patients requiring physical rehabilitation for orthopaedic disorders, particularly chronic low back pain.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LumbaCure
LumbaCure® is a device developed to induce specific mobilization of the lower back in patients requiring physical rehabilitation for orthopaedic disorders, particularly chronic low back pain.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject, a resident or worker at the investigation site (nursing home), over 60 years of age
* Ability to communicate with the physiotherapist.
* Ability to remain in a sitting position for at least 10 minutes.
* A level of back pain \> 2 on the numerical pain rating scale
Exclusion Criteria
* Body weight \> 120 kg
* Subject is non-ambulatory or has severely reduced mobility.
* Dominant component of radicular pain (common lumbago with distal radiation below the knee)
* Radiculopathy
* Severe cardiorespiratory disease
* Dementia or significant cognitive impairment that prevents the participant from giving consent, completing study questionnaires or complying with recommendations.
* Fracture or operation less than 3 months old of the spine, pelvis, hip or leg bones.
* Known vertebral pathology other than osteoarthritis.
* Major neurological disease, movement or motor neuron disorders
* Fibromyalgia or other systemic rheumatic disease
* Recent history of stroke or heart failure, unstable heart condition
* Uncontrolled substance abuse disorders
* Invasive procedures to relieve pain in the last 3 months
* Acute or terminal illness
* Any other medical condition considered by the study team to be a contraindication to the study.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASBL " Mère Joséphine " - MRS Saint Joseph Blegny
Blégny, Liège, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIV-23-09-043961
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.